How do individuals decide whether to accept or decline an offer of genetic testing for colorectal cancer?
نویسندگان
چکیده
Background Since 1997, the Victorian Colorectal Cancer Family Study (VCCFS) has been studying a large number of individuals who have had colorectal cancer and their relatives. When a genetic mutation is identified by the VCCFS, family members are offered the chance to have genetic testing through a family cancer clinic to learn of their result. Between 17% (before August 2003) and 49% (after August 2003) of individuals offered genetic testing decline the offer [1], providing a unique opportunity to conduct research with individuals who decline genetic testing. Understanding this decision making process is critical to improving the uptake of genetic testing in practice [2].
منابع مشابه
“How should we treat older patients with Metastatic Colorectal Cancer, A Review”
Nearly 50 % of newly diagnosed colorectal cancer, affect people over 70 years of age. Inclusion of older patients in clinical trials has been extremely rare. As a result, there is debate on how to manage these patients because it is still unclear how to balance the therapeutic advantages and toxicities. For patients who do not have comorbid conditions, with performance status (P.S.) 0–1, treatm...
متن کاملI-14: The Impact of Disclosure Decisions on Donor Gamete Participants: Donors, Intended Parents and Offspring
To discuss the psychological impact of disclosure decisions on donor gamete participants including gamete donors, intended parents, and the children conceived through these third party reproductive techniques. In the past decade, there has been a dramatic increase worldwide in the number of children born as a result of gamete donation. The growing demand for these programs has resulted in a tre...
متن کاملScreening for Lynch Syndrome in the General Population Health Benefits and Cost-Effectiveness of Primary Genetic
In current clinical practice, genetic testing to detect Lynch syndrome mutations ideally begins with diagnostic testing of an individual affected with cancer before offering predictive testing to at-risk relatives. An alternative strategy that warrants exploration involves screening unaffected individuals via demographic and family histories, and offering genetic testing to those individuals wh...
متن کاملHealth benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.
In current clinical practice, genetic testing to detect Lynch syndrome mutations ideally begins with diagnostic testing of an individual affected with cancer before offering predictive testing to at-risk relatives. An alternative strategy that warrants exploration involves screening unaffected individuals via demographic and family histories, and offering genetic testing to those individuals wh...
متن کاملGenetic polymorphisms of superoxide dismutase-1 A251G and catalase C-262T with the risk of colorectal cancer
Oxidative stress is significant in numerous types of disease including cancer. To protect cells and organs against reactive oxygen species (ROS), the body has evolved an antioxidant protection system that involved in the detoxification of ROS. Single nucleotide polymorphisms (SNP) of anti-oxidative enzymes may dramatically change the activity of the encoded proteins; therefore, certain alleles ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 9 شماره
صفحات -
تاریخ انتشار 2011